Washington D.C. is preparing to move on efforts to penalize companies that move their headquarters overseas to benefit from lower corporate tax rates.
Covidien penetrates home-based patient monitoring through an agreement licensing its ZephyrLIFE telehealth solutions to Geneia for integration into their @Home platform.
Medtech titan Covidien (NYSE:COV) is breaching new ground in home care with its ZephyrLIFE remote monitoring platform, agreeing to license the technology to healthcare solutions company Geneia.
Here's a look at some of the top Wall Street stories for medical device companies this week: Renal denervation isn't dead, despite Medtronic trial's failure; Baxter says HQ will stay in Illinois, stays coy on Boston plans; Private equity owners rebrand KCI, Systagenix, LifeCell as Acelity
, Apax Partners
, Baxter International
, Boston Scientific
, Centaur Guernsey
, Kinetic Concepts Inc.
, Kona Medical
, LifeCell Corp.
, ReCor Medical
, St. Jude Medical
, Systagenix Wound Management Inc.
Here's a look at some of the top mergers & acquisitions stories for medical device companies this week: Covidien acquires Sapheon and its VenaSeal varicose vein treatment; Medtronic to cover $58M tax tab for top execs in Covidien buy; Report: J&J puts Cordis on the block; Another Covidien shareholder sues over Medtronic deal; Allergan accedes to special meeting, asks court to block Valeant's vote
MassDevice.com looks at the internet chatter surrounding the medical device industry with some of most searched-for companies of the last month.
MassDevice.com looked at some of the most talked-about medical device companies, based on trends in U.S. Google searches for the last 30 days.
The failure of Medtronic's Symplicity 3 trial doesn't mean the end of renal denervation in treated resistant hypertension, especially in Europe, but future studies face a high bar set by the Medtronic trial's sham control arm.
Here's a look at some of the top legal news stories for medical device companies this week: ArthroCare ex-CEO faces 30-year sentence for fraud; Shareholders sue Edap following FDA slip; Ex-sales rep wins class action status in lawsuit against Stryker; Another Covidien shareholder sues over Medtronic deal; Respiratory rivals ResMed, BMC each tally wins in Trade Commission ruling